Clinical Trials Directory

Trials / Completed

CompletedNCT02125630

Bone Metastasis and Surgery in Breast Cancer

The Effect of Primary Surgery in Patients With Stage IV Breast Cancer With Bone Metastasis Only

Status
Completed
Phase
Study type
Observational
Enrollment
460 (actual)
Sponsor
Federation of Breast Diseases Societies · Academic / Other
Sex
Female
Age
20 Years – 80 Years
Healthy volunteers
Not accepted

Summary

A registry trial evaluating resection of the primary breast tumor in women presenting with de novo stage IV breast cancer with bone metastasis only. Previous reports of carefully selected patients presenting with stage IV breast cancer suggest that surgery on the primary tumor may result in improved survival, but this remains unproven. The early results of our ongoing trial MF07-01 trial (a phase III randomized controlled trial of breast cancer women with distant metastases at presentation who receive loco-regional treatment for intact primary tumor compared with those who do not receive such treatment) showed that patients with bone metastasis only have a trend toward improved survival with initial surgery.

Detailed description

This registry trial evaluating resection of the primary breast tumor in women presenting with de novo stage IV breast cancer with bone metastasis only. Previous reports of carefully selected patients presenting with stage IV breast cancer suggest that surgery on the primary tumor may result in improved survival, but this remains unproven. The early results of our ongoing trial MF07-01 trial (a phase III randomized controlled trial of breast cancer women with distant metastases at presentation who receive loco-regional treatment for intact primary tumor compared with those who do not receive such treatment) showed that patients with bone metastasis only have a trend toward improved survival with initial surgery. Our goal is to test if primary surgery improves overall survival in bone only metastasis.

Conditions

Interventions

TypeNameDescription
PROCEDURESurgerySurgery to primary tumor
DRUGSystemic therapySystemic therapy based on tumor phenotype

Timeline

Start date
2014-01-01
Primary completion
2019-06-01
Completion
2019-06-01
First posted
2014-04-29
Last updated
2019-07-31

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT02125630. Inclusion in this directory is not an endorsement.